Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de documento
País/Região como assunto
Ano de publicação
Intervalo de ano de publicação
1.
Blood Coagul Fibrinolysis ; 29(3): 267-274, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29474203

RESUMO

: The renin-angiotensin system plays an important role in the regulation of blood pressure and the development of coronary artery disease. The aim was to examine the association of the insertion deletion in the angiotensin-converting enzyme gene, M235T and T174M polymorphisms in the angiotensinogen gene with ST elevation acute myocardial infarction (STEAMI) in young Mexican population. We analyzed 242 unrelated patients with STEAMI 45 or less years of age, admitted to a cardiovascular intense care unit, and 242 individuals without STEAMI matched by age and sex, recruited from January 2006 and June 2013. The polymorphisms insertion deletion, M235T and T174M were determined in all participants by a polymerase chain-reaction-restriction fragment length polymorphism assay. There was a significant difference in the insertion deletion genotype distribution between two groups (P = 0.03) and a higher percentage of the T allele M235T polymorphism in the group of STEAMI patients (P = 0.02). The T174M polymorphism was not associated (P = 0.08). The insertion deletion and M235T polymorphisms, smoking, hypertension, familial history of cardiovascular disease and dyslipidemia were independent risk factors for STEAMI. Our results identified that the D allele from the insertion deletion and M235T but not T174M polymorphisms represent an independent risk factor for STEAMI in young Mexican population.


Assuntos
Polimorfismo Genético , Sistema Renina-Angiotensina/genética , Infarto do Miocárdio com Supradesnível do Segmento ST/etiologia , Adulto , Angiotensinogênio/genética , Humanos , México , Pessoa de Meia-Idade , Risco , Fatores de Risco , Adulto Jovem
2.
Cell Signal ; 16(11): 1239-47, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15337523

RESUMO

Activation of the interleukin-2 receptor (IL-2R) induces signalling cascades promoting T cell proliferation. However, signal transduction pathways triggered in IL-2R-expressing solid tumours are unknown. This report shows that human papillomavirus (HPV)-associated cervical cancer cells express an IL-2R composed of beta and gamma chains (IL-2Rbetagamma), and that IL-2-mediated activation increases the phosphorylation of JAK3 and STAT5, stimulating cell proliferation. Interestingly, endogenous IL-2 is not produced by these cells, suggesting the activation of IL-2Rbetagamma by an alternative mechanism. Accordingly, we found that Stem Cell Factor (SCF)-activated c-Kit induces phosphorylation of the IL-2Rbeta chain in the absence of IL-2. Moreover, inhibition of IL-2Rbeta phosphorylation by blocking c-Kit tyrosine kinase activity abolishes both, IL-2 and SCF-mediated proliferation. Thus, these results demonstrate that IL-2 triggers a JAK3/STAT5 cascade in HPV-associated cervical cancer cells expressing IL-2Rbetagamma, and that this receptor can be alternatively activated by SCF-activated c-Kit in the absence of IL-2.


Assuntos
Carcinoma/imunologia , Proteínas de Ligação a DNA/imunologia , Proteínas do Leite/imunologia , Papillomaviridae/imunologia , Proteínas Tirosina Quinases/imunologia , Proteínas Proto-Oncogênicas c-kit/imunologia , Receptores de Interleucina-2/imunologia , Transativadores/imunologia , Neoplasias do Colo do Útero/imunologia , Carcinoma/virologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/imunologia , Humanos , Interleucina-2/imunologia , Interleucina-2/farmacologia , Janus Quinase 3 , Fosforilação/efeitos dos fármacos , Subunidades Proteicas/imunologia , Proteínas Proto-Oncogênicas c-kit/efeitos dos fármacos , Fator de Transcrição STAT5 , Transdução de Sinais/genética , Transdução de Sinais/imunologia , Fator de Células-Tronco/metabolismo , Fator de Células-Tronco/farmacologia , Neoplasias do Colo do Útero/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA